PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA

Case report: Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his ch...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Seda Şahin, Neriman Sarı, Derya Özyörük, Sonay İncesoy Özdemir, Belgin Gülhan, İnci Ergürhan İlhan
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/a7cf8bc9770c428a9af6e87997a36166
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a7cf8bc9770c428a9af6e87997a36166
record_format	dspace
spelling	oai:doaj.org-article:a7cf8bc9770c428a9af6e87997a361662021-11-10T04:34:19ZPROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA2531-137910.1016/j.htct.2021.10.1007https://doaj.org/article/a7cf8bc9770c428a9af6e87997a361662021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2531137921011548https://doaj.org/toc/2531-1379Case report: Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his chemotherapy altough he is still COVID-19 positive. We didn't see any complication. Prolonged COVID-19 positivity is thought to be associated with the infection of immortal malignant cells located in the nasopharynxSeda ŞahinNeriman SarıDerya ÖzyörükSonay İncesoy ÖzdemirBelgin Gülhanİnci Ergürhan İlhanElsevierarticleDiseases of the blood and blood-forming organsRC633-647.5ENHematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S31- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the blood and blood-forming organs RC633-647.5
spellingShingle	Diseases of the blood and blood-forming organs RC633-647.5 Seda Şahin Neriman Sarı Derya Özyörük Sonay İncesoy Özdemir Belgin Gülhan İnci Ergürhan İlhan PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
description	Case report: Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his chemotherapy altough he is still COVID-19 positive. We didn't see any complication. Prolonged COVID-19 positivity is thought to be associated with the infection of immortal malignant cells located in the nasopharynx
format	article
author	Seda Şahin Neriman Sarı Derya Özyörük Sonay İncesoy Özdemir Belgin Gülhan İnci Ergürhan İlhan
author_facet	Seda Şahin Neriman Sarı Derya Özyörük Sonay İncesoy Özdemir Belgin Gülhan İnci Ergürhan İlhan
author_sort	Seda Şahin
title	PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_short	PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_full	PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_fullStr	PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_full_unstemmed	PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_sort	prolonged covid-19 positivity and chemotherapy in a patient with nasopharengeal carcinoma
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/a7cf8bc9770c428a9af6e87997a36166
work_keys_str_mv	AT sedasahin prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma AT nerimansarı prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma AT deryaozyoruk prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma AT sonayincesoyozdemir prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma AT belgingulhan prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma AT inciergurhanilhan prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma
_version_	1718440584919646208

PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA

Ejemplares similares